Milestone Pharmaceuticals (MIST) Net Income towards Common Stockholders (2018 - 2026)
Milestone Pharmaceuticals' Net Income towards Common Stockholders came in at -$14.56 million for Q3 2022, compared with -$14.23 million a year earlier.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2022, Milestone Pharmaceuticals reported Net Income towards Common Stockholders of -$62.31 million; for FY2021, it came in at -$42.85 million.
- Going back by year, Net Income towards Common Stockholders was -$49.97 million in FY2020, -$55.23 million in FY2019 and -$23.19 million in FY2018.
- The five-year range for quarterly Net Income towards Common Stockholders is -$18.29 million (Q4 2019) to $770,000 (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Milestone Pharmaceuticals | 82.17 Mn | -88.43 Mn | 527,000.00 | -28.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.61 Mn |
| Mar 31, 2026 | -26.07 Mn |
| Dec 31, 2025 | -17.41 Mn |
| Sep 30, 2025 | -11.92 Mn |
| Jun 30, 2025 | -12.97 Mn |
| Mar 31, 2025 | -20.76 Mn |
| Dec 31, 2024 | -12.36 Mn |
| Sep 30, 2024 | -9.44 Mn |
| Jun 30, 2024 | -9.36 Mn |
| Mar 31, 2024 | -10.35 Mn |
| Dec 31, 2023 | -13.61 Mn |
| Sep 30, 2023 | -15.08 Mn |
| Jun 30, 2023 | -16.04 Mn |
| Mar 31, 2023 | -14.95 Mn |
| Dec 31, 2022 | -13.18 Mn |
| Sep 30, 2022 | -14.56 Mn |
| Jun 30, 2022 | -16.65 Mn |
| Mar 31, 2022 | -14.01 Mn |
| Dec 31, 2021 | -16.88 Mn |
| Sep 30, 2021 | -14.23 Mn |
API Access
Milestone Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=MIST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "MIST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=MIST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();